Cayasan, Rexcel C.

HRN: 11-42-73  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/01/2024
CEFUROXIME 1.5GM (VIAL)
02/01/2024
02/08/2024
IV
1.5 Grams
Every 8 Hours
Hemorrhoids Stage III For Hemorrhoidectomy
Waiting Final Action 
02/01/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2024
02/02/2024
IV
500 Mg
1 Hour Prior To OR
Hemorrhoids Grade III For Hemorrhoidectomy
Waiting Final Action 
02/02/2024
CEFUROXIME 1.5GM (VIAL)
02/02/2024
02/05/2024
IV
1.5
Q8h
Post Op
Waiting Final Action 
02/02/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/02/2024
02/05/2024
IV
500mg
Q8h
Post Op
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: